Dr. Thomas Laedtke, MD (he/him) is an Endocrinologist in Edina, MN with over 16 years of experience. What is your opinion of Dr. Thomas Laedtke, MD? Rate this provider below so other people can make informed decision.
Over 16 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Thomas Laedtke, MD has received over $238,029 which includes payments from the following companies:
$225,671.12 from Novo Nordisk Inc
$10,444.58 from AbbVie, Inc.
$1,067.11 from Medtronic MiniMed, Inc.
$144.09 from Boehringer Ingelheim Pharmaceuticals, Inc.
$131.57 from INSULET CORPORATION
$103.76 from Shire North American Group Inc
$83.59 from Abbott Laboratories
$68.66 from Novartis Pharmaceuticals Corporation
$47.78 from Eisai Inc.
$45.20 from GlaxoSmithKline, LLC.
$30.02 from Valeritas, Inc.
$24.87 from Ipsen Biopharmaceuticals, Inc
$23.90 from Janssen Pharmaceuticals, Inc
$20.85 from AstraZeneca Pharmaceuticals LP
$20.50 from Corcept Therapeutics
$18.41 from Tandem Diabetes Care, Inc.
$17.15 from OPKO Pharmaceuticals, LLC
$15.62 from AKRIMAX PHARMACEUTICALS, LLC
$15.02 from sanofi-aventis U.S. LLC
$12.13 from Auxilium Pharmaceuticals, Inc.
Payments received by Dr. Thomas Laedtke, MD were from the following categories:
$153,353.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!